alexa Electrical stimulation of unloaded muscles causes cardiovascular exercise by increasing oxygen demand.


Journal of Clinical & Experimental Cardiology

Author(s): Banerjee P, Clark A, Witte K, Crowe L, Caulfield B

Abstract Share this page

Abstract BACKGROUND: The development of new strategies to encourage increased levels of physical activity can help to reduce the incidence of cardiovascular disease. A new system of electrical muscle stimulation (EMS) has been developed that attempts to cause an increase in energy expenditure by mimicking the action of shivering in the body. The purpose of this study was to show that this form of EMS is capable of eliciting a cardiovascular exercise response in healthy adults. DESIGN: An observational study. METHODS: Ten healthy volunteers completed a maximal treadmill test and four EMS sessions using a hand-held EMS device that delivered current to the body via five silicone rubber electrodes on each leg. At each session subjects completed 3 min stimulation at each of four stimulation outputs (10, 20, 30 and 40\% of maximum output) while cardiopulmonary gas exchange and heart rate (HR) were measured. Physiological responses at increasing levels of stimulation were evaluated. RESULTS: Average (+/-SD) HR and oxygen consumption (VO2) levels of 67+/-11 bpm and 4.7+/-1.2 ml/kg per min at rest, respectively, were increased to 186+/-10 bpm and 44.9+/-9.8 ml/kg per min at peak exercise intensity on treadmill testing. The electrical stimulation was generally well tolerated by the subjects. Subjects demonstrated statistically significant increases in all physiological variables measured with successive increases in stimulation intensity. Peak HR and VO2 at 40\% stimulation intensity were 101+/-12 bpm and 14.9+/-4.3 ml/kg per min, respectively. CONCLUSIONS: These results demonstrate that this form of EMS is capable of producing a physiological response consistent with cardiovascular exercise at mild to moderate intensities. It achieves this without producing gross movement of the limbs or loading of the joints. This EMS-induced cardiovascular exercise response could be used to promote increased levels of physical activity in populations unable to participate in voluntary exercise.
This article was published in Eur J Cardiovasc Prev Rehabil and referenced in Journal of Clinical & Experimental Cardiology

Relevant Expert PPTs

Relevant Speaker PPTs

  • Donald silverberg
    Is correction of iron deficiency a new addition to the treatment of heart failure?
    PPT Version | PDF Version
  • Ahmed Zeidan
    Effects of intravenous iron in chronic kidney disease and heart failure
    PPT Version | PDF Version
  • Yosef Yarden
    Classically, the 3’untranslated region (3’UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3’UTR alone, without all other elements in mRNA such as 5’UTR and coding region. The importance of independent 3’UTR RNA (referred as I3’UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3’UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3’UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3’UTR were important for its tumor suppression activity. Then, the C/EBP 3’UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3’UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3’UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990’s to 2000’s, world scientists found several 3’UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3’UTR regions, although the existence of their transcribed products as independent 3’UTR RNAs is still to be confirmed. Our studies indicate that the independent 3’UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
    PPT Version | PDF Version
  • Ishfaq A Bukhari
    Protective Effect of Diltiazem and Fenofibrate Against Ischemia-reperfusion Induced Cardiac Arrhythmias in the Isolated Rat Heart.
    PPT Version | PDF Version
  • A Martin Gerdes
    Wrong about β-blockers! Wrong about positive inotropes! Wrong about Thyroid Hormone treatment of Heart Failure?
    PDF Version
  • Fatih Yalcin
    PDF Version
  • Samuel C Dudley
    Novel biomarkers for diastolic heart failure
    PDF Version
  • Abdulaziz U Joury
    Acute Myocardial Infarction as First Presentation among patients with Coronary Heart Disease
    PPT Version | PDF Version
  • Helena Dominguez
    Can we protect the brain against thromboembolism during open heart surgery? LAACS project
    PDF Version
  • Saverio Gentile
    Ion channels phosphorylopathy: 3rd International Conference on Clinical & Experimental Cardiology April 15-17, 2013 A link between genomic variations and heart arrhythmia
    PDF Version

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version